Modeling psychiatric disorders with patient-derived iPSCs

Zhexing Wen, Kimberly M. Christian, Hongjun Song, Guo li Ming

Research output: Contribution to journalArticle

Abstract

Psychiatric disorders are heterogeneous disorders characterized by complex genetics, variable symptomatology, and anatomically distributed pathology, all of which present challenges for effective treatment. Current treatments are often blunt tools used to ameliorate the most severe symptoms, often at the risk of disrupting functional neural systems, thus there is a pressing need to develop rational therapeutics. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an unprecedented opportunity to recapitulate both normal and pathologic human tissue and organ development, and provides new approaches for understanding disease mechanisms and for drug discovery with higher predictability of their effects in humans. Here we review recent progress and challenges in using human iPSCs for modeling neuropsychiatric disorders and developing novel therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)118-127
Number of pages10
JournalCurrent Opinion in Neurobiology
Volume36
DOIs
StatePublished - Feb 1 2016

Fingerprint

Induced Pluripotent Stem Cells
Psychiatry
Drug Discovery
Therapeutics
Pathology

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Modeling psychiatric disorders with patient-derived iPSCs. / Wen, Zhexing; Christian, Kimberly M.; Song, Hongjun; Ming, Guo li.

In: Current Opinion in Neurobiology, Vol. 36, 01.02.2016, p. 118-127.

Research output: Contribution to journalArticle

Wen, Zhexing ; Christian, Kimberly M. ; Song, Hongjun ; Ming, Guo li. / Modeling psychiatric disorders with patient-derived iPSCs. In: Current Opinion in Neurobiology. 2016 ; Vol. 36. pp. 118-127.
@article{4f8b611400d94e7c842ff0e93b3c41a8,
title = "Modeling psychiatric disorders with patient-derived iPSCs",
abstract = "Psychiatric disorders are heterogeneous disorders characterized by complex genetics, variable symptomatology, and anatomically distributed pathology, all of which present challenges for effective treatment. Current treatments are often blunt tools used to ameliorate the most severe symptoms, often at the risk of disrupting functional neural systems, thus there is a pressing need to develop rational therapeutics. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an unprecedented opportunity to recapitulate both normal and pathologic human tissue and organ development, and provides new approaches for understanding disease mechanisms and for drug discovery with higher predictability of their effects in humans. Here we review recent progress and challenges in using human iPSCs for modeling neuropsychiatric disorders and developing novel therapeutic strategies.",
author = "Zhexing Wen and Christian, {Kimberly M.} and Hongjun Song and Ming, {Guo li}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.conb.2015.11.003",
language = "English (US)",
volume = "36",
pages = "118--127",
journal = "Current Opinion in Neurobiology",
issn = "0959-4388",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Modeling psychiatric disorders with patient-derived iPSCs

AU - Wen, Zhexing

AU - Christian, Kimberly M.

AU - Song, Hongjun

AU - Ming, Guo li

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Psychiatric disorders are heterogeneous disorders characterized by complex genetics, variable symptomatology, and anatomically distributed pathology, all of which present challenges for effective treatment. Current treatments are often blunt tools used to ameliorate the most severe symptoms, often at the risk of disrupting functional neural systems, thus there is a pressing need to develop rational therapeutics. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an unprecedented opportunity to recapitulate both normal and pathologic human tissue and organ development, and provides new approaches for understanding disease mechanisms and for drug discovery with higher predictability of their effects in humans. Here we review recent progress and challenges in using human iPSCs for modeling neuropsychiatric disorders and developing novel therapeutic strategies.

AB - Psychiatric disorders are heterogeneous disorders characterized by complex genetics, variable symptomatology, and anatomically distributed pathology, all of which present challenges for effective treatment. Current treatments are often blunt tools used to ameliorate the most severe symptoms, often at the risk of disrupting functional neural systems, thus there is a pressing need to develop rational therapeutics. Induced pluripotent stem cells (iPSCs) reprogrammed from patient somatic cells offer an unprecedented opportunity to recapitulate both normal and pathologic human tissue and organ development, and provides new approaches for understanding disease mechanisms and for drug discovery with higher predictability of their effects in humans. Here we review recent progress and challenges in using human iPSCs for modeling neuropsychiatric disorders and developing novel therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=84949757589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949757589&partnerID=8YFLogxK

U2 - 10.1016/j.conb.2015.11.003

DO - 10.1016/j.conb.2015.11.003

M3 - Article

C2 - 26705693

AN - SCOPUS:84949757589

VL - 36

SP - 118

EP - 127

JO - Current Opinion in Neurobiology

JF - Current Opinion in Neurobiology

SN - 0959-4388

ER -